Crossmark

Tailored brain metastatic tumor cells-derived apoptotic bodies ameliorate Alzheimer’s disease by promoting microglia efferocytosis and neuroinflammation mitigation

Crossref DOI link: https://doi.org/10.1186/s12951-025-03750-y

Published Online: 2025-10-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mu, Zhenlong

Chen, Yang

Hu, Yunfeng

Wang, Hui

Li, Jin
Funding

Funding for this research was provided by:

Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX25_3261)

National Natural Science Foundation of China (No. 81502997)
License Information

Text and Data Mining valid from 2025-10-09

Version of Record valid from 2025-10-09
More Information

Article History

Received: 10 May 2025

Accepted: 26 September 2025

First Online: 9 October 2025

Declarations

:

: The protocol for animal experiments was approved by the Institutional Animal Care and Use Committee of Xuzhou Medical University and had received approval from the Animal Investigation Ethics Committee of Xuzhou Medical University (SYXK 2020–0048).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below